Pandemic Defense Platform Designed for Surge-Scaling Rapid Antigen Testing at the Point of Contact
The key to getting people back to a full, healthy life is the ability to scale access to accurate, rapid, and affordable testing
By transforming the COVID-19 rapid antigen testing arena at the point of collection, we're creating a pandemic defense and economic recovery platform with the needs of business in mind. High efficiency. Thousands of tests an hour. Individual results in 10 minutes.
The Critical Role of Antigen Testing
The Food and Drug Administration (FDA) has acknowledged the vital role of antigen tests in the overall response to COVID-19, correctly characterizing them as rapid, point-of-care tests with high scalability.
- The FDA has authorized COVID-19 antigen tests under Emergency Use Authorization’s; but all are low throughput.
- In September 2020, FluroTest confirmed the successful function of its novel, proprietary, and highly sensitive real-time, point-of-care antigen test, which uses fluorescence spectroscopy to quantify the SARS-CoV-2 viral load in salivary samples.